| [1] |
Pievani A, Borleri G, Pende D, et al. Dual-functional capability of CD3＋CD56＋CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity [J]. Blood, 2011, 118(12): 3301-3310.
|
| [2] |
Zhang YS, Yuan FJ, Jia GF, et al. CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R [J]. World J Gastroenterol, 2005, 11(22): 3339-3345.
|
| [3] |
Sangiolo D, Mesiano G, Gammaitoni L, et al. Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas [J]. Cancer Res, 2014, 74(1): 119-129.
|
| [4] |
Tao Q, Chen T, Tao L, et al. IL-15 improves the cytotoxicity of cytokine-induced killer cells against leukemia cells by upregulating CD3＋CD56＋ cells and downregulating regulatory T cells as well as IL-35 [J]. J Immunother, 2013, 36(9): 462-467.
|
| [5] |
Rajbhandary S, Zhao MF, Zhao N, et al. Multiple cytotoxic factors involved in IL-21 enhanced antitumor function of CIK cells signaled through STAT-3 and STAT5b pathways [J]. Asian Pac J Cancer Prev, 2013, 14(10): 5825-5831.
|
| [6] |
Kim HM, Lim J, Yoon YD, et al. Anti-tumor activity of ex vivo expanded cytokine-induced killer cells against human hepatocellular carcinoma [J]. Int Immunopharmacol, 2007, 7(13): 1793-1801.
|
| [7] |
Linn YC, Lau SK, Liu BH, et al. Characterization of the recognition and functional heterogeneity exhibited by cytokine-induced killer cell subsets against acute myeloid leukaemia target cell [J]. Immunology, 2009, 126(3): 423-435.
|
| [8] |
Franceschetti M, Pievani A, Borleri G, et al. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes [J]. Exp Hematol, 2009, 37(5): 616-628.e2.
|
| [9] |
Brinkmann OA, Bruns F, Gosheger G, et al. Treatment of bone metastases and local recurrence from renal cell carcinoma with immunochemotherapy and radiation [J]. World J Urol, 2005, 23(3): 185-190.
|
| [10] |
何金媛，贾祝霞，蔡晓辉, 等. NKG2D在细胞因子诱导的杀伤性细胞(CIK)抗血液肿瘤细胞的作用 [J]. 中国实验血液学杂志, 2013, 21(6): 1380-1384.
|
| [11] |
Bahram S, Shiina T, Oka A, et al. Genomic structure of the human MHC class I MICB gene [J]. Immunogenetics, 1996, 45(2): 161-162.
|
| [12] |
Xu X, Rao GS, Groh V, et al. Major histocompatibility complex class I-related chain A/B(MICA/B)expression in tumor tissue and serum of pancreatic cancer: role of uric acid accumulation in gemcitabine-induced MICA/B expression [J]. BMC Cancer, 2011, 11: 194.
|
| [13] |
Bae JH, Kim SJ, Kim MJ, et al. Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction [J]. Cancer Sci, 2012, 103(1): 7-16.
|
| [14] |
Mehta BA, Schmidt-Wolf IG, Weissman IL, et al. Two pathways of exocytosis of cytoplasmic granule contents and target cell killing by cytokine-induced CD3＋ CD56＋ killer cells [J]. Blood, 1995, 86(9): 3493-3499.
|
| [15] |
Kuçi S, Rettinger E, Voss B, et al. Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation [J]. Haematologica, 2010, 95(9): 1579-1586.
|
| [16] |
李花，孙抒，杨万山, 等. CIK细胞对A549肺癌细胞株的诱导凋亡作用的研究 [J]. 实用肿瘤杂志, 2011, 26(4): 356-359.
|
| [17] |
孙抒，李雪梅，王建光, 等. CIK细胞对MGC-803胃癌细胞株抗增殖及诱导凋亡作用的研究 [J]. 中国免疫学杂志, 2004, 20(12): 831-833, 837.
|
| [18] |
庞佳楠，崔久嵬. 细胞因子诱导的杀伤细胞治疗肿瘤的研究进展 [J]. 中华临床医师杂志(电子版), 2014, 8(15): 2889-2893.
|
| [19] |
Kim YJ, Lim J, Kang JS, et al. Adoptive immunotherapy of human gastric cancer with ex vivo expanded T cells [J]. Arch Pharm Res, 2010, 33(11): 1789-1795.
|
| [20] |
Shi L, Zhou Q, Wu J, et al. Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer [J]. Cancer Immunol Immunother, 2012, 61(12): 2251-2259.
|
| [21] |
Tumeh PC, Koya RC, Chodon T, et al. The impact of ex vivo clinical grade activation protocols on human T-cell phenotype and function for the generation of genetically modified cells for adoptive cell transfer therapy [J]. J Immunother, 2010, 33(8): 759-768.
|
| [22] |
Huang J, Li C, Wang Y, et al. Cytokine-induced killer(CIK)cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high)cancer stem cells in vitro and in vivo [J]. Clin Immunol, 2013, 149(1): 156-168.
|
| [23] |
刘洪一，李荣，刘巨超, 等. 双特异性单抗对胃肠癌的体内杀伤作用 [J]. 实用临床医药杂志, 2012, 16(5): 19-22.
|
| [24] |
王美梅，张南征，陈复兴, 等. 白桦酯酸对人CIK细胞杀伤胃癌细胞株SGC-7901的功能影响及机制研究 [J]. 中华微生物学和免疫学杂志, 2012, 32(1): 48-53.
|
| [25] |
Yu X, Xia W, Zhang T, et al. Enhanced cytotoxicity of IL-24 gene-modified dendritic cells co-cultured with cytokine-induced killer cells to hepatocellular carcinoma cells [J]. Int J Hematol, 2010, 92(2): 276-282.
|
| [26] |
陈艳，刘辉，于丽, 等. 表达新型干扰素的CIK细胞对结肠癌的治疗作用 [J]. 中华实验外科杂志, 2011, 28(12): 2158-2161.
|
| [27] |
Li XD, Xu B, Wu J, et al. Review of Chinese clinical trials on CIK cell treatment for malignancies [J]. Clin Transl Oncol, 2012, 14(2): 102-108.
|
| [28] |
Shi L, Zhou Q, Wu J, et al. Efficacy of adjuvant immunotherapy with cytokine-induced killer cells in patients with locally advanced gastric cancer [J]. Cancer Immunol Immunother, 2012, 61(12): 2251-2259.
|
| [29] |
Baselga J. Why the epidermal growth factor receptor? The rationale for cancer therapy [J]. Oncologist, 2002, 7(Suppl 4): 2-8.
|
| [30] |
李建旺，彭大为，黄春珍, 等. 自体CIK细胞及DC细胞联合索拉非尼治疗晚期肝癌的临床观察 [J]. 实用癌症杂志, 2011, 26(5): 459-461.
|
| [31] |
Ramakrishnan R, Assudani D, Nagaraj S, et al. Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice [J]. J Clin Invest, 2010, 120(4): 1111-1124.
|
| [32] |
李辉，毛伟征，安岗, 等. 细胞因子诱导杀伤细胞杀伤胃癌的特异性与非特异性研究 [J]. 中华实验外科杂志, 2010, 27(4): 428-430.
|
| [33] |
Huang ZM, Li W, Li S, et al. Cytokine-induced Killer Cells in Combination With Transcatheter Arterial Chemoembolization and Radiofrequency Ablation for Hepatocellular Carcinoma Patients [J]. J Immunother, 2013, 36(5): 287-293.
|
| [34] |
Wang XP, Xu M, Gao HF, et al. Intraperitoneal perfusion of cytokine-induced killer cells with local hyperthermia for advanced hepatocellular carcinoma [J]. World J Gastroenterol, 2013, 19(19): 2956-2962.
|